ABP 215
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABP 215, covering 2017-10-19 to 2023-07-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 3]